Breaking News, Collaborations & Alliances

VGXI Taps Cryoport for Biostorage and Bioservices

Partnership will support the development of cell and gene therapies and mRNA-based treatments.

Author Image

By: Charlie Sternberg

Associate Editor

Cryoport Inc., a leader in supply chain solutions for the life sciences, and VGXI Inc.,a contract developer and manufacturer specializing in nucleic acid biopharmaceuticals, have announced a strategic partnership to support the development of cell and gene therapies and mRNA-based treatments.   Through this new partnership, Cryoport Systems will provide biostorage and bioservices from its Houston, Texas, facility for plasmid DNA products manufactured at VGXI’s facilities in The Woodlands...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters